Latham & Watkins and Wilson Sonsini Goodrich & Rosati advised Fractyl Health on the transaction, and Goodwin Procter advised the underwriters. Fractyl Health (Nasdaq: GUTS) announced the...
Fractyl Health’s $110 Million Initial Public Offering
Amring Pharmaceuticals’ Acquisition of Visant Medical
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo advised Amring Pharmaceuticals Inc. on the transaction, and Wilson Sonsini Goodrich & Rosati advised Visant Medical. Amring Pharmaceuticals Inc....
Ceribell’s $53 Million Series C Financing
Wilson Sonsini Goodrich & Rosati advised Ceribell on the deal. Ceribell, innovator of the Rapid Response EEG™, a novel non-invasive brain monitor, announced the completion of...